|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 14.55 CNY | +0.83% |
|
-0.68% | -14.51% |
| Dec. 05 | Tasly Pharmaceutical Subsidiary Gets Drug Registration for Muscle Spasms Drug | MT |
| Oct. 28 | Tasly Pharmaceutical's Q3 Profit Falls 45%; Shares Slide 3% | MT |
| Capitalization | 21.74B 2.99B 2.83B 2.62B 2.35B 4.23B 253B 4.68B 32.64B 12.07B 104B 11.23B 10.98B 448B | P/E ratio 2024 * |
21.2x | P/E ratio 2025 * | 16.7x |
|---|---|---|---|---|---|
| Enterprise value | 20.34B 2.8B 2.65B 2.45B 2.2B 3.96B 237B 4.38B 30.54B 11.29B 97.36B 10.51B 10.28B 419B | EV / Sales 2024 * |
2.28x | EV / Sales 2025 * | 2x |
| Free-Float |
49.28% | Yield 2024 * |
1.79% | Yield 2025 * | 2.71% |
More valuation ratios
* Estimated data
More news
More press releases
More news
| 1 day | +0.83% | ||
| 1 week | -0.68% | ||
| Current month | -0.68% | ||
| 1 month | -8.20% | ||
| 3 months | +1.75% | ||
| 6 months | +6.05% | ||
| Current year | -14.51% |
1 week
14.29
14.83
1 month
14.2516.09
Current year
12.2417.77
1 year
12.2418.00
3 years
9.2018.00
5 years
9.2019.97
10 years
9.2041.32
| Director | Title | Age | Since |
|---|---|---|---|
Jin Yong Cai
CEO | Chief Executive Officer | 52 | 2024-05-07 |
Jie Wei
DFI | Director of Finance/CFO | 47 | 2018-07-08 |
Ying Zhao
IRC | Investor Relations Contact | - | - |
| Manager | Title | Age | Since |
|---|---|---|---|
Xiao Meng Jiang
BRD | Director/Board Member | 60 | 2007-08-16 |
Ai Jian Wang
BRD | Director/Board Member | 70 | 2021-06-01 |
Jin Yong Cai
BRD | Director/Board Member | 52 | 2006-03-24 |
| Change | 5d. change | 1-year change | 3-years change | Capi. ($) | ||
|---|---|---|---|---|---|---|
| +0.83% | -0.68% | -5.40% | +6.52% | 2.99B | ||
| +0.12% | -0.73% | +14.74% | +32.97% | 5.08B | ||
| +1.19% | -1.16% | -29.79% | +4.03% | 3.91B | ||
| +0.91% | -0.71% | -8.35% | +24.00% | 2.94B | ||
| +1.73% | +1.48% | -1.67% | -8.21% | 2.51B | ||
| +0.95% | +4.19% | -2.98% | -1.17% | 1.75B | ||
| -2.03% | +1.69% | +33.39% | +83.13% | 1.72B | ||
| +0.58% | -1.18% | -3.39% | -14.95% | 1.64B | ||
| +0.84% | -1.81% | +71.17% | +111.28% | 1.59B | ||
| +1.75% | +2.64% | -31.76% | -38.74% | 1.33B | ||
| Average | +0.69% | -0.67% | +3.60% | +19.89% | 2.55B | |
| Weighted average by Cap. | +0.69% | -0.91% | +1.23% | +19.43% |
| 2024 * | 2025 * | |
|---|---|---|
| Net sales | 8.91B 1.23B 1.16B 1.08B 962M 1.73B 104B 1.92B 13.38B 4.95B 42.65B 4.6B 4.5B 184B | 9.42B 1.3B 1.23B 1.14B 1.02B 1.83B 110B 2.03B 14.15B 5.23B 45.11B 4.87B 4.76B 194B |
| Net income | 1.02B 140M 133M 123M 110M 199M 11.89B 220M 1.53B 567M 4.89B 528M 516M 21.06B | 1.3B 179M 170M 157M 141M 254M 15.2B 281M 1.96B 724M 6.25B 674M 659M 26.91B |
| Net Debt | -1.4B -192M -182M -168M -151M -271M -16.26B -300M -2.1B -775M -6.68B -721M -705M -28.78B | -2.86B -394M -372M -345M -309M -557M -33.33B -616M -4.3B -1.59B -13.7B -1.48B -1.45B -59.01B |
More financial data
* Estimated data
Employees
9,223
Sector
Pharmaceuticals
Calendar
2025-04-16
- Q4 2024 Earnings Release (Projected)
| Date | Price | Change | Volume |
|---|---|---|---|
| 24-12-06 | 14.55 ¥ | +0.83% | 10,473,500 |
| 24-12-05 | 14.43 ¥ | -0.62% | 9,812,500 |
| 24-12-04 | 14.52 ¥ | -1.22% | 9,772,100 |
| 24-12-03 | 14.70 ¥ | -0.14% | 9,748,327 |
| 24-12-02 | 14.72 ¥ | +0.48% | 10,795,830 |
End-of-day quote Shanghai S.E., December 05, 2024
More quotes
Sell
Buy
Mean consensus
BUY
Number of Analysts
8
Last Close Price
14.55CNY
Average target price
17.36CNY
Spread / Average Target
+19.29%
Quarterly revenue - Rate of surprise
- Stock Market
- Equities
- 600535 Stock